Page last updated: 2024-08-26

bosentan anhydrous and Cardiac Toxicity

bosentan anhydrous has been researched along with Cardiac Toxicity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abdel-Gaber, SA; Hafez, SMNA; Khalaf, HM; Rahman, SAAE; Refaie, MMM	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Cardiac Toxicity

Article	Year
Cardioprotective effects of bosentan in 5-fluorouracil-induced cardiotoxicity. Toxicology, 2022, 01-15, Volume: 465 Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Bosentan; Cardiotoxicity; Endothelin Receptor Antagonists; Fluorouracil; Heart Diseases; Myeloid Differentiation Factor 88; Myocytes, Cardiac; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Wistar; Receptors, Endothelin; Signal Transduction; Toll-Like Receptor 4	2022

Article

Year

Cardioprotective effects of bosentan in 5-fluorouracil-induced cardiotoxicity.

Toxicology, 2022, 01-15, Volume: 465

Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Bosentan; Cardiotoxicity; Endothelin Receptor Antagonists; Fluorouracil; Heart Diseases; Myeloid Differentiation Factor 88; Myocytes, Cardiac; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Stress; Rats, Wistar; Receptors, Endothelin; Signal Transduction; Toll-Like Receptor 4

2022